small is an ingredient
in formulation

When nanoformed API particles are formulated in the right way, their full potential is unlocked. They can deliver material and performance attributes that are highly differentiated and create novelty in the formulations they touch.

In order to overcome the low solubility and poor bioavailability of small molecules, it is essential that an optimized formulation tailored specifically for API nanoparticles is developed.

Leveraging a deep understanding of nanomaterials science and nanoformation expertise, we follow a well-designed formulation development and selection process to deliver the formulation that meets your requirements. We use analytical and in vitro tools in-house and have well-established collaborations with external partners to deliver in vivo data.

Dissolution and permeability performance of API X

We support all dosage form development and have specific expertise in oral, inhaled, injectable and ophthalmic formulations. Our goal is to rapidly progress your drug candidate and optimize the formulation appropriately for the development phase, from preclinical through clinic and life cycle.